J. Uy

558 total citations
13 papers, 260 citations indexed

About

J. Uy is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, J. Uy has authored 13 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Emergency Medicine. Recurrent topics in J. Uy's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and HIV-related health complications and treatments (4 papers). J. Uy is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and HIV-related health complications and treatments (4 papers). J. Uy collaborates with scholars based in United States, Germany and France. J. Uy's co-authors include John D. Baxter, Rodger D. MacArthur, Barry Schmetter, Katherine Huppler Hullsiek, Michael J. Kozal, Ying Xiang, Grace Peng, Mary van den Berg-Wolf, Richard M. Novak and Moris Angulo and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Infectious Diseases.

In The Last Decade

J. Uy

12 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Uy United States 7 149 120 63 57 35 13 260
Tianjun Jiang China 10 97 0.7× 38 0.3× 82 1.3× 18 0.3× 35 1.0× 21 227
Alessandra Calabresi Italy 10 150 1.0× 94 0.8× 78 1.2× 94 1.6× 11 0.3× 15 297
Ashwini Shete India 10 101 0.7× 102 0.8× 55 0.9× 20 0.4× 9 0.3× 31 263
Filippa Bonura Italy 10 178 1.2× 61 0.5× 192 3.0× 179 3.1× 6 0.2× 16 297
Ross Murtagh Ireland 9 108 0.7× 78 0.7× 116 1.8× 68 1.2× 25 0.7× 16 306
G. Carosi Italy 9 123 0.8× 64 0.5× 63 1.0× 91 1.6× 17 0.5× 22 254
Romualdo Mazzi Italy 8 142 1.0× 74 0.6× 128 2.0× 25 0.4× 19 0.5× 16 316
Jake Scott United States 10 131 0.9× 18 0.1× 57 0.9× 68 1.2× 48 1.4× 15 350
D Gotti Italy 11 120 0.8× 84 0.7× 108 1.7× 111 1.9× 4 0.1× 21 372
Paola Zuccalà Italy 8 77 0.5× 36 0.3× 125 2.0× 14 0.2× 31 0.9× 13 278

Countries citing papers authored by J. Uy

Since Specialization
Citations

This map shows the geographic impact of J. Uy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Uy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Uy more than expected).

Fields of papers citing papers by J. Uy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Uy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Uy. The network helps show where J. Uy may publish in the future.

Co-authorship network of co-authors of J. Uy

This figure shows the co-authorship network connecting the top 25 collaborators of J. Uy. A scholar is included among the top collaborators of J. Uy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Uy. J. Uy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Karon, Barry L., Clare O’Connor, Jennifer Leaning, et al.. (2023). A-373 Comparison of the CoaguChek ® and Coag-Sense ® PT2 Meter Point of Care INR Devices. Clinical Chemistry. 69(Supplement_1).
2.
Puig, L., Tsen‐Fang Tsai, Tina Bhutani, et al.. (2020). Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials. Journal of the European Academy of Dermatology and Venereology. 34(8). 1744–1749. 21 indexed citations
3.
Uy, J., et al.. (2014). Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level. Clinical Kidney Journal. 7(2). 186–189. 18 indexed citations
4.
5.
6.
Squires, K., et al.. (2010). Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. Journal of Antimicrobial Chemotherapy. 66(2). 363–370. 30 indexed citations
7.
Uy, J., et al.. (2010). Clinical significance of hyperbilirubinemia in the CASTLE study. Journal of the International AIDS Society. 13(S4). 3 indexed citations
8.
Albano, Jessica D., Hugh H. Tilson, J. Uy, et al.. (2010). Assessing the risk of birth defects associated with atazanavir exposure in pregnancy. Journal of the International AIDS Society. 13. P113–P113. 1 indexed citations
9.
Venook, Alan P., Amy Ko, Margaret A. Tempero, et al.. (2008). Phase II trial of FOLFOX plus bevacizumab in advanced, progressive neuroendocrine tumors. Journal of Clinical Oncology. 26(15_suppl). 15545–15545. 42 indexed citations
10.
Uy, J., et al.. (2008). Efficacy and safety by baseline HIV-RNA and CD4 count in treatment-naive patients treated With atazanavir/r and lopinavir/r in the CASTLE study. Journal of the International AIDS Society. 11(Suppl 1). P8–P8. 7 indexed citations
11.
Novak, Richard M., Rodger D. MacArthur, John D. Baxter, et al.. (2005). Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy. Clinical Infectious Diseases. 40(3). 468–474. 104 indexed citations
12.
Angulo, Moris, et al.. (1993). Male Hypogonadism with Gynecomastia Caused by Late-Onset Deficiency of Testicular 17-Ketosteroid Reductase. New England Journal of Medicine. 328(18). 1297–1301. 25 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianjun Jiang Breakdown of academic impact, for papers by Alessandra Calabresi Breakdown of academic impact, for papers by Ashwini Shete Breakdown of academic impact, for papers by Filippa Bonura Breakdown of academic impact, for papers by Ross Murtagh Breakdown of academic impact, for papers by G. Carosi Breakdown of academic impact, for papers by Romualdo Mazzi Breakdown of academic impact, for papers by Jake Scott Breakdown of academic impact, for papers by D Gotti Breakdown of academic impact, for papers by Paola Zuccalà
Rankless by CCL
2026